Barry J. Regan - 20 Apr 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Signature
By: Jereme Sylvain For: Barry Regan
Issuer symbol
DXCM
Transactions as of
20 Apr 2023
Net transactions value
-$275,643
Form type
4
Filing time
20 Apr 2023, 18:39:43 UTC
Previous filing
14 Mar 2023
Next filing
10 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale $275,643 -2,214 -3.1% $124.50 68,258 20 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
F2 Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024.